Leaflet ONBREZ BREEZHALER 300mcg capsules with inhalation powder
Indicated for: chronic obstructive pulmonary disease
Route of administration: inhalation
Substance: indacaterol (beta-2 adrenergic agonist)
ATC: R03AC18 (Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists)
Indacaterol is a bronchodilator used to treat chronic obstructive pulmonary disease (COPD). It belongs to the class of long-acting beta-2 adrenergic agonists and helps relax the muscles of the airways, making breathing easier.
The medication is administered via inhalation, usually once daily, as directed by a doctor.
Side effects may include cough, headache, dizziness, or throat irritation. In rare cases, severe allergic reactions or palpitations may occur.
Patients should strictly follow the usage instructions and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
General data about ONBREZ BREEZHALER 300mcg
- Substance: indacaterol
- Date of last drug list: 01-05-2026
- Commercial code: W64464002
- Concentration: 300mcg
- Pharmaceutical form: capsules with inhalation powder
- Quantity: 30
- Product type: original
- Price: 137.30 RON
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Concentrations available for indacaterol
- 150mcg
- 300mcg
Combinations with other substances
Compensation lists for ONBREZ BREEZHALER 300mcg Europharm
B - Sublist B with 50% discount from the reference price
Price
Copayment
Patient
137.30 RON
68.65 RON
68.65 RON